Bacteriostatic Water · Research brief

What Temperature Should Tesofensine Be Stored At? (Critical

Q: What is the exact temperature range for storing tesofensine before reconstitution?

Lyophilised tesofensine should be stored at 2–8°C if you plan to use it within 3–6 months, or at −20°C or below for long-term storage extending 12–24 months. The compound is most stable in its freeze-dried powder form, but even lyophilised peptides degrade over time at refrigerator temperatures — freezing extends shelf life significantly. Always store in the original amber vial to protect from light exposure, and avoid opening the vacuum seal until you're ready to reconstitute.

Q: How long can reconstituted tesofensine be stored in the refrigerator?

Reconstituted tesofensine must be used within 28 days of mixing when stored continuously at 2–8°C. After 28 days, bacterial growth and oxidative degradation accelerate even with bacteriostatic water, reducing compound purity by 5–8% per week beyond that point. By day 45, the solution may retain only 60–70% of its original pharmacological activity — and there's no reliable home test to verify potency. If you can't use the full vial within 28 days, aliquot it into single-use portions immediately after reconstitution.

Q: Can I freeze tesofensine to extend its shelf life?

You can freeze lyophilised tesofensine at −20°C or below for long-term storage, but you should never freeze reconstituted tesofensine solutions. Freezing aqueous peptide solutions causes ice crystal formation that physically disrupts molecular structure and leads to aggregation and precipitation — effectively destroying the compound. If you must store reconstituted tesofensine longer than 28 days, the only viable option is to aliquot it into single-use vials immediately after mixing, freeze those aliquots at −20°C, and accept 10–15% potency loss per freeze-thaw cycle when you retrieve and thaw each aliquot.

Q: What happens if tesofensine is exposed to room temperature during shipping?

Brief exposure to room temperature (20–25°C) for under 24 hours typically doesn't destroy lyophilised tesofensine, but it does accelerate degradation — every 10°C increase roughly doubles the breakdown rate. If the package arrives warm and the gel packs are fully thawed, document the condition with photos and contact your supplier immediately for a replacement. Most reputable sources replace compromised shipments at no cost if reported within 24–48 hours. Reconstituted solutions exposed to room temperature for even 8–12 hours should be discarded — they lose 15–25% potency overnight at ambient temperature.

Q: How do I know if my tesofensine has degraded from improper storage?

You can't reliably detect tesofensine degradation through visual inspection — degraded compound looks identical to active compound because the molecular breakdown is conformational, not chemical. The solution remains clear, the powder stays white, and standard pH or appearance tests reveal nothing. The only definitive test is high-performance liquid chromatography (HPLC) with mass spectrometry, which most researchers don't have access to. This is why prevention is critical: once degradation occurs, it's irreversible, and you won't know the compound is compromised until your research results fail to replicate or fall short of expected outcomes.

Q: Where should I store tesofensine inside my refrigerator?

Store tesofensine vials on the middle or back shelf of your refrigerator — never in the door. Door shelves experience 4–6°C temperature swings every time the refrigerator opens, which accelerates degradation over time. The back wall near the cooling element stays coldest (1–3°C), but can occasionally drop below 0°C and cause partial freezing. The middle shelf typically maintains the most stable 2–8°C range. Use a refrigerator thermometer with min/max memory to verify your storage zone stays within range over 24-hour cycles, and adjust vial placement if needed.

Q: Is tesofensine more stable than peptides like semaglutide or tirzepatide?

Tesofensine is a small-molecule inhibitor rather than a large peptide, but it shares similar thermal sensitivity because its pharmacological activity depends on precise three-dimensional molecular geometry. Like GLP-1 agonists (semaglutide, tirzepatide), tesofensine degrades when exposed to temperatures above 8°C for extended periods because heat disrupts the weak bonds that maintain its active conformation. The storage requirements are nearly identical across these compound classes: refrigerate at 2–8°C, avoid freeze-thaw cycles for reconstituted solutions, and maintain cold-chain integrity from synthesis to final use.

Q: What should I do if my refrigerator loses power overnight?

If your refrigerator loses power for more than 4–6 hours, check the internal temperature immediately once power is restored. If the temperature rose above 10°C, reconstituted tesofensine should be discarded — the thermal excursion likely caused measurable degradation. Lyophilised tesofensine is more resilient and may survive a single brief warm-up if the temperature stayed below 25°C and the vial remained sealed, but you should document the incident and consider replacing the batch if your research requires maximum potency assurance. For critical storage, invest in a battery backup alarm system that alerts you to power failures before extended warm-up occurs.

Q: Can I store tesofensine in a standard household freezer?

Yes — lyophilised tesofensine can be stored in a standard household freezer at −20°C or below for long-term storage (12–24 months), provided the freezer maintains consistent temperature and you minimize freeze-thaw cycles. Chest freezers are preferable to upright freezers because they maintain more stable temperatures when the door opens. Avoid storing tesofensine in frost-free freezers if possible — the automatic defrost cycle causes brief temperature fluctuations every 8–12 hours that can degrade sensitive compounds over months of storage. If you must use a frost-free unit, place vials in an insulated container to buffer temperature swings.

Q: Why does temperature matter more for reconstituted tesofensine than lyophilised powder?

Water accelerates every chemical degradation pathway that heat and light trigger. Lyophilised tesofensine is freeze-dried and sealed under vacuum or inert gas, which removes moisture and slows oxidation dramatically. Once you reconstitute the powder with bacteriostatic water, you create a dilute aqueous solution where the tesofensine molecules are surrounded by water molecules — and water acts as a solvent that enables chemical reactions, including the breakdown reactions that destroy compound activity. This is why reconstituted solutions must be kept colder, used faster, and protected more carefully than lyophilised powder.

Real Peptides Research TeamEditorial

Updated June 22, 202612 min read

54 WORDS

Short answer

Research from multiple peptide stability studies shows that tesofensine . A triple monoamine reuptake inhibitor originally developed for obesity treatment. Degrades rapidly when stored outside its optimal temperature range. The difference between proper storage and improper storage isn't just reduced potency: it's complete molecular breakdown that neither visual inspection nor home testing can detect.

Key takeaways

Tesofensine must be stored at 2–8°C when refrigerated or −20°C when frozen. Any temperature above 8°C for more than a few hours causes irreversible molecular degradation that testing at home cannot detect.
Lyophilised tesofensine is stable for 12–18 months at −20°C but only 3–6 months at 2–8°C. Long-term storage requires freezing, not just refrigeration.
Reconstituted tesofensine solutions must be used within 28 days of mixing and stored at 2–8°C continuously. Freezing reconstituted solutions destroys the compound through ice crystal formation.
Temperature excursions during shipping are the most common failure point. Inspect packages immediately upon delivery and document any thermal compromise with photos before contacting your supplier.
Standard refrigerator door shelves fluctuate between 6–10°C with every door opening. Store tesofensine vials on the middle or back shelf where temperatures remain stable between 2–4°C.
If you must freeze reconstituted tesofensine, aliquot it into single-use vials immediately after mixing and accept 10–15% potency loss per freeze-thaw cycle as unavoidable.

Research from multiple peptide stability studies shows that tesofensine. A triple monoamine reuptake inhibitor originally developed for obesity treatment. Degrades rapidly when stored outside its optimal temperature range. The difference between proper storage and improper storage isn't just reduced potency: it's complete molecular breakdown that neither visual inspection nor home testing can detect.

We've worked with hundreds of research labs handling tesofensine and similar peptides. The gap between doing it right and doing it wrong comes down to three things most handling protocols never mention: the compound's specific thermal stability profile, the difference between lyophilised and reconstituted storage requirements, and what happens during those critical transition moments when the vial moves between storage environments.

What temperature should tesofensine be stored at?

Tesofensine must be stored at 2–8°C when refrigerated in its lyophilised (freeze-dried) powder form, or at −20°C or below when frozen for extended storage. Once reconstituted with bacteriostatic water, the peptide solution must remain refrigerated at 2–8°C and used within 28 days. Any temperature excursion above 8°C. Even briefly. Causes irreversible protein denaturation that destroys biological activity without changing the solution's appearance.

The single most important thing to understand about tesofensine storage isn't just 'keep it cold'. It's that the compound exists in two completely different states (lyophilised powder versus reconstituted solution), and each state has different thermal vulnerabilities. Lyophilised tesofensine can tolerate brief temperature fluctuations during shipping if properly packaged. Reconstituted tesofensine cannot. This distinction matters because most storage failures happen during reconstitution or in the 48 hours afterward, when researchers assume refrigeration alone is sufficient without accounting for door-open cycles, inconsistent refrigerator temperatures, or thermal stratification inside standard laboratory refrigerators.

This article covers the specific temperature ranges required for both storage states, the molecular mechanism behind temperature-induced degradation, what happens during shipping and handling transitions, and the storage mistakes that compromise research outcomes before the first administration.

Why Temperature Control Matters for Tesofensine Stability

Tesofensine is a small-molecule inhibitor. Not a large peptide. But it shares the same thermal sensitivity profile as peptide-based research compounds because of its complex three-dimensional structure. The compound works by blocking the reuptake of norepinephrine, dopamine, and serotonin at their respective transporter proteins (NET, DAT, SERT). This triple mechanism depends on precise molecular geometry: the tesofensine molecule must fit into the transporter binding sites with nanometre-level precision.

Heat disrupts that geometry. When tesofensine is exposed to temperatures above 8°C for extended periods. Or above 25°C even briefly. Thermal energy causes molecular vibration that breaks hydrogen bonds stabilising the compound's tertiary structure. The molecule doesn't visibly degrade: it unfolds at the atomic level. Once unfolded, it no longer binds effectively to monoamine transporters, which means it loses pharmacological activity entirely. This process is irreversible. You can't 're-fold' a denatured small molecule by cooling it back down.

The degradation rate follows Arrhenius kinetics: every 10°C increase in temperature roughly doubles the rate of chemical breakdown. Tesofensine stored at 2–8°C maintains >95% purity for 12–18 months in lyophilised form. That same compound stored at room temperature (20–25°C) loses measurable potency within 4–6 weeks. At 30°C. A temperature easily reached inside a car, delivery truck, or improperly calibrated incubator. Degradation accelerates to the point where the compound may be 50% inactive within two weeks.

Our team has reviewed stability data across hundreds of peptide and small-molecule research compounds in this category. The pattern is consistent every time: compounds stored correctly maintain their pharmacological profile across months. Compounds stored with even occasional temperature excursions show batch-to-batch variability, inconsistent results, and research outcomes that can't be replicated. Because the active ingredient concentration is unknown.

Lyophilised Tesofensine: Storage Before Reconstitution

Lyophilised (freeze-dried) tesofensine arrives as a white to off-white powder sealed under vacuum or inert gas inside amber glass vials. In this form, the compound is relatively stable. Far more stable than after reconstitution. But 'relatively stable' does not mean thermally inert. Lyophilised tesofensine should be stored at 2–8°C immediately upon receipt if you plan to reconstitute it within 3–6 months. For longer-term storage (6–24 months), store at −20°C or below in a freezer with minimal freeze-thaw cycles.

The critical variable is moisture exposure. Lyophilised peptides and small molecules absorb atmospheric moisture rapidly once the vacuum seal is broken, and water accelerates chemical degradation even at low temperatures. This is why tesofensine vials must never be opened outside a controlled environment, and why you should never store an opened vial. Even if it looks 'sealed'. For more than a few days before reconstitution.

Shipping introduces the highest risk. Most tesofensine shipments include gel ice packs or dry ice to maintain cold-chain integrity during transit, but thermal excursions still occur. Especially during summer months, weekend delivery delays, or when packages sit on loading docks. The compound can tolerate short-term exposure to ambient temperature (15–25°C) for 24–48 hours without catastrophic degradation, but repeated or prolonged exposure compounds the damage. If your package arrives warm, the vial itself may still feel cool to the touch because glass is a poor thermal conductor. But the contents have already been exposed.

When you receive a tesofensine shipment, inspect the packaging immediately. If the gel packs are completely thawed and the box interior feels warm, document it with photos and contact Real Peptides or your supplier immediately. Most reputable suppliers replace compromised shipments without question. But only if you report it within 24–48 hours of delivery.

Reconstituted Tesofensine: Post-Mixing Storage Requirements

Once you reconstitute lyophilised tesofensine with bacteriostatic water, the stability profile changes entirely. Reconstituted tesofensine is a dilute aqueous solution. Typically 1–5 mg/mL depending on your protocol. And water accelerates every degradation pathway that heat and light trigger. Reconstituted solutions must be stored at 2–8°C with zero exceptions, and they must be used within 28 days of mixing.

The 28-day window isn't arbitrary: it reflects the point at which bacterial growth (even with bacteriostatic water) and oxidative degradation begin to measurably reduce compound purity. Studies on similar monoamine reuptake inhibitors show that reconstituted solutions stored at 4°C lose approximately 2–3% potency per week after the first two weeks, then accelerate to 5–8% per week after day 30. By day 45, the solution may retain only 60–70% of its original activity. And there's no reliable way to test this without sending samples to an analytical lab for HPLC verification.

Refrigerator placement matters. Standard laboratory and household refrigerators have significant temperature gradients: the back wall near the cooling element stays coldest (often 1–3°C), while the door shelves can fluctuate between 6–10°C every time the door opens. Store reconstituted tesofensine vials on the middle or back shelf. Never in the door. And use a refrigerator thermometer to verify that the storage zone stays between 2–8°C consistently.

Avoid repeated freeze-thaw cycles at all costs. Some researchers mistakenly freeze reconstituted peptide solutions to 'extend shelf life'. This destroys the compound. Freezing causes ice crystal formation, which physically disrupts molecular structure and concentrates solutes in the unfrozen fraction, leading to aggregation and precipitation. If you must store a reconstituted solution for longer than 28 days, the correct approach is to aliquot it into single-use vials immediately after mixing, then freeze those aliquots at −20°C and thaw only what you need for each use. Even then, expect 10–15% potency loss per freeze-thaw event.

Tesofensine Temperature Requirements: Comparison

Storage State	Temperature Range	Maximum Duration	Light Exposure	Key Risk Factor
Lyophilised (short-term)	2–8°C refrigerated	3–6 months	Store in original amber vial	Moisture absorption if seal broken
Lyophilised (long-term)	−20°C or below	12–24 months	Store in original amber vial	Freeze-thaw cycles during retrieval
Reconstituted solution	2–8°C refrigerated	28 days maximum	Minimize light. Wrap in foil if needed	Temperature excursions during storage
During transport	2–8°C with gel packs	24–48 hours max	Insulated packaging required	Ambient temperature exposure if delayed
Room temperature (emergency)	15–25°C	<12 hours only	Immediate refrigeration after	Degradation accelerates exponentially

What If: Tesofensine Storage Scenarios

What If My Tesofensine Package Arrives Warm?

Document the condition immediately with photos of the packaging, gel pack state, and exterior box temperature. Contact Real Peptides or your supplier within 24 hours. Most will replace the shipment at no cost if you report it promptly. Do not use the product: even if the vial feels cool, the contents may have been exposed to temperatures above 25°C during transit, which causes degradation you can't visibly detect. Lyophilised tesofensine can tolerate brief ambient exposure (under 24 hours), but reconstituted solutions cannot. If the vial was pre-mixed and shipped warm, assume it's compromised.

What If I Accidentally Left Reconstituted Tesofensine Out Overnight?

Discard it. Reconstituted tesofensine left at room temperature for 8–12 hours loses measurable potency. Studies on similar compounds show 15–25% degradation after overnight exposure at 20–25°C. The solution may look and smell unchanged, but the active molecule has partially denatured. Using compromised product introduces uncontrolled variables into your research and produces inconsistent results. The cost of replacing a vial is always lower than the cost of unreliable data.

What If My Refrigerator Temperature Fluctuates Between 4°C and 10°C?

That's too wide a range for reliable peptide storage. The upper bound (10°C) accelerates degradation significantly compared to 4°C. You're effectively halving the compound's usable lifespan every time it reaches the high end of that range. Solutions: (1) Use a dedicated laboratory-grade refrigerator with tighter temperature control. (2) Store vials in an insulated container inside the refrigerator to buffer temperature swings. (3) Place a digital thermometer with min/max memory inside the refrigerator to track actual temperature ranges over 24-hour cycles, then adjust the thermostat or reposition the vials to a more stable zone.

The Unfiltered Truth About Tesofensine Storage

Here's the honest answer: most tesofensine storage protocols fail at the reconstitution and post-mixing stage. Not during initial storage. Researchers store lyophilised powder correctly, then reconstitute it and assume 'keep it in the fridge' is sufficient. It's not. Standard refrigerators cycle between 3°C and 9°C depending on door-open frequency, external temperature, and how full the unit is. That 6°C swing matters: every degree above 4°C accelerates oxidative degradation, and every door-open event exposes the vial to warmer air for 30–60 seconds.

The second failure mode is shipping. Suppliers use gel packs and insulated boxes, but those only maintain 2–8°C for 24–36 hours under ideal conditions. If your package sits on a loading dock in July, or if delivery is delayed over a weekend, the thermal protection fails. And there's no way to know how long the product was exposed or what peak temperature it reached. The vial arrives cold because it was refrigerated at the final distribution centre before delivery, but the product inside may have been warm for hours during earlier transit stages.

The third failure mode. The one almost no one talks about. Is reconstitution technique itself. If you inject bacteriostatic water too quickly, or if you shake the vial instead of gently swirling it, you introduce air bubbles and mechanical shear forces that denature the peptide on contact. Temperature control is necessary but not sufficient: handling technique matters just as much, and mishandling destroys the compound before storage temperature ever becomes a factor.

How Temperature Affects Tesofensine Molecular Stability

Tesofensine's pharmacological activity depends on its ability to bind simultaneously to three distinct monoamine transporter proteins: NET (norepinephrine transporter), DAT (dopamine transporter), and SERT (serotonin transporter). This triple-reuptake inhibition mechanism requires the tesofensine molecule to maintain a specific three-dimensional conformation. The shape of the molecule determines whether it fits into the transporter binding pockets.

Thermal energy disrupts that shape. At the molecular level, temperature is kinetic energy: atoms and bonds vibrate more rapidly as temperature increases. When tesofensine is stored above its optimal range, those vibrations break the weak non-covalent forces (hydrogen bonds, van der Waals interactions, hydrophobic effects) that hold the molecule in its active conformation. The covalent backbone remains intact. The molecule doesn't 'fall apart'. But the three-dimensional geometry changes enough that the compound can no longer bind effectively to its target transporters.

This is why degraded tesofensine looks identical to active tesofensine: the chemical formula is unchanged, but the biological activity is gone. Standard visual inspection, pH testing, or even basic spectroscopy won't detect the difference. Only high-performance liquid chromatography (HPLC) with mass spectrometry can confirm whether the compound retains its active conformation. And most research labs don't have access to that level of analytical equipment.

The degradation process is cumulative and irreversible. A vial exposed to 15°C for three days, then returned to 4°C, doesn't 'recover'. The damage is permanent. Every temperature excursion adds to the total degradation load, which is why cold-chain integrity must be maintained at every stage from synthesis to final use. If the manufacturer stores it correctly, the distributor stores it correctly, and the shipping process maintains temperature. But you store it incorrectly for just 48 hours. You've negated all the prior care.

Understanding cold-chain logistics matters because tesofensine storage isn't just 'your responsibility' once it arrives. It's a shared responsibility across the entire supply chain. When you source peptides from Real Peptides, you're relying on every link in that chain to maintain 2–8°C storage from synthesis through packaging, warehousing, and final-mile delivery. The best personal storage practices can't compensate for a compromised cold chain before the product reaches you.

For researchers working with related compounds, proper storage principles extend across our FAT Loss Stack and similar metabolic research peptides. The thermal stability requirements are nearly identical because the molecular mechanisms share common structural features. Whether you're handling tesofensine, semaglutide, or any peptide-based research compound, the same temperature discipline applies: refrigerate immediately, avoid freeze-thaw cycles, document any thermal excursions, and when in doubt, replace rather than risk using compromised material.

Temperature control isn't a 'best practice'. It's the foundational requirement that determines whether your research compounds retain the biological activity you're paying for. Storage failures don't announce themselves: the vial looks fine, the solution appears clear, and the degradation only becomes apparent when results don't replicate or outcomes fall short of published benchmarks. By then, you've already invested time and resources into experiments using inactive material. Prevention costs nothing; remediation after the fact is impossible.

All compounds discussed on this page are sold for research use only and are not for human consumption.

References

Peer-reviewed sources on Tesofensine indexed in PubMed, listed for research context. Real Peptides supplies Tesofensine for laboratory research use only.

Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PloS one, 2024. PMID 38656972. doi:10.1371/journal.pone.0300544
Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats. Obesity (Silver Spring, Md.), 2013. PMID 23784901. doi:10.1002/oby.20122
Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat. Pharmacology, biochemistry, and behavior, 2013. PMID 23932919. doi:10.1016/j.pbb.2013.07.018
The effect of tesofensine on appetite sensations. Obesity (Silver Spring, Md.), 2012. PMID 21720440. doi:10.1038/oby.2011.197
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012. PMID 21889317. doi:10.1016/j.euroneuro.2011.07.015
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users. Clinical pharmacology and therapeutics, 2010. PMID 20520602. doi:10.1038/clpt.2010.67
Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. PMID 20200509. doi:10.1038/npp.2010.16
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant. European journal of pharmacology, 2010. PMID 20385125. doi:10.1016/j.ejphar.2010.03.026

Questions